Gupta, D. L., Meher, J., Giri, A. K., Shukla, A. K., Mohapatra, E., Ruikar, M. M. and Rao, D. (2024) “RBD mutations at the residues K417, E484, N501 reduced immunoreactivity with antisera from vaccinated and COVID-19 recovered patients”, Drug Target Insights, 18(1), pp. 20–26. doi: 10.33393/dti.2024.3059.